#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA1794345	F	PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]	Plasmodium falciparum	170,142	ALA1201862	organism-based format	PubChem BioAssays
2.	ALA4395491	B	Inhibition of GCase in human SH-SY5Y cells using MUG-Gluc as fluorogenic substrate preincubated for 30 mins followed by substrate addition and measured after 2 hrs in presence of conduritol B epoxide by fluorescence based assay	Homo sapiens	15	ALA4393698	cell-based format	Scientific Literature
3.	ALA4395492	B	Inhibition of GCase in human SH-SY5Y cells at 1 nM to 1 mM using MUG-Gluc as fluorogenic substrate preincubated for 30 mins followed by substrate addition and measured after 2 hrs in presence of conduritol B epoxide by fluorescence based assay relative to control	Homo sapiens	15	ALA4393698	cell-based format	Scientific Literature
4.	ALA4395493	B	Inhibition of NLGase in human SH-SY5Y cells using MUG-Gluc as fluorogenic substrate preincubated for 30 mins followed by substrate addition and measured after 2 hrs in presence of AMP-DNM by fluorescence based assay	Homo sapiens	15	ALA4393698	cell-based format	Scientific Literature
5.	ALA4395494	B	Inhibition of NLGase in human SH-SY5Y cells at 1 nM to 1 mM using MUG-Gluc as fluorogenic substrate preincubated for 30 mins followed by substrate addition and measured after 2 hrs in presence of AMP-DNM by fluorescence based assay relative to control	Homo sapiens	15	ALA4393698	cell-based format	Scientific Literature
6.	ALA4395495	F	Anti-inflammatory activity in human CuFi1 cells assessed as reduction in Pseudomonas aeruginosa PAO1-induced IL-8 mRNA expression level at 0.1 uM pretreated for 1 hr followed by Pseudomonas aeruginosa PAO1 challenge and measured after 4 hrs by RT-PCR analysis relative to control	Homo sapiens	7	ALA4393698	cell-based format	Scientific Literature
7.	ALA4395496	F	Anti-inflammatory activity in human CuFi1 cells assessed as reduction in Pseudomonas aeruginosa PAO1-induced IL-8 mRNA expression level pretreated for 1 hr followed by Pseudomonas aeruginosa PAO1 challenge and measured after 4 hrs by RT-PCR analysis	Homo sapiens	5	ALA4393698	cell-based format	Scientific Literature
8.	ALA4395497	F	Anti-inflammatory activity in human CuFi1 cells assessed as reduction in Pseudomonas aeruginosa PAO1-induced IL-8 mRNA expression level pretreated for 1 hr followed by Pseudomonas aeruginosa PAO1 challenge and measured after 4 hrs by RT-PCR analysis relative to control	Homo sapiens	4	ALA4393698	cell-based format	Scientific Literature
9.	ALA4395498	F	Anti-inflammatory activity in human Bronchial epithelial cells assessed as reduction in Pseudomonas aeruginosa PAO1-induced IL-8 mRNA expression level at 10 nM pretreated for 1 hr followed by Pseudomonas aeruginosa PAO1 challenge and measured after 4 hrs by RT-PCR analysis relative to control	Homo sapiens	2	ALA4393698	assay format	Scientific Literature
10.	ALA4395499	A	Induction of apoptosis in human CuFi1 cells incubated for 48 hrs by Muse Annexin V based cell counter assay	Homo sapiens	9	ALA4393698	cell-based format	Scientific Literature
11.	ALA4395500	A	Cytotoxicity against human CuFi1 cells assessed as reduction in cell viability incubated for 48 hrs by Muse cell analyser method	Homo sapiens	9	ALA4393698	cell-based format	Scientific Literature
12.	ALA4395501	F	Anti-inflammatory activity in Pseudomonas aeruginosa PAO1 infected C57Bl/6NCr mouse assessed as reduction in amount of neutrophils in lungs at 100 mg/kg, po administered via gavage pretreated for 1 to 24 hrs followed by Pseudomonas aeruginosa PAO1 challenge and measured after 6 hrs	Pseudomonas aeruginosa	1	ALA4393698	organism-based format	Scientific Literature
13.	ALA4395502	F	Anti-inflammatory activity in Pseudomonas aeruginosa PAO1 infected C57Bl/6NCr mouse assessed as increase in alveolar macrophages in lungs at 10 mg/kg, po administered via gavage pretreated for 1 to 24 hrs followed by Pseudomonas aeruginosa PAO1 challenge and measured after 6 hrs	Pseudomonas aeruginosa	1	ALA4393698	organism-based format	Scientific Literature
14.	ALA4395503	F	Anti-inflammatory activity in Pseudomonas aeruginosa PAO1 infected C57Bl/6NCr mouse assessed as reduction in bacterial CFU in BAL at 10 mg/kg, po administered via gavage pretreated for 1 to 24 hrs followed by Pseudomonas aeruginosa PAO1 challenge and measured after 6 hrs	Pseudomonas aeruginosa	1	ALA4393698	organism-based format	Scientific Literature
15.	ALA4395504	F	Anti-inflammatory activity in Pseudomonas aeruginosa PAO1 infected C57Bl/6NCr mouse assessed as reduction in bacterial CFU in lungs at 10 mg/kg, po administered via gavage pretreated for 1 to 24 hrs followed by Pseudomonas aeruginosa PAO1 challenge and measured after 6 hrs	Pseudomonas aeruginosa	1	ALA4393698	organism-based format	Scientific Literature
16.	ALA4395505	T	Toxicity in Pseudomonas aeruginosa PAO1 infected C57Bl/6NCr mouse assessed as change in body weight at 100 mg/kg, po administered via gavage pretreated for 1 to 24 hrs followed by Pseudomonas aeruginosa PAO1 challenge and measured after 6 hrs	Mus musculus	1	ALA4393698	organism-based format	Scientific Literature
17.	ALA4808149	B	Enzymatic assay of human HDAC6 with commercial peptide substrate	Homo sapiens	5,603	ALA4808148	single protein format	Fraunhofer HDAC6
18.	ALA4808150	B	Enzymatic assay of human HDAC6 with custom peptide substrate	Homo sapiens	5,603	ALA4808148	single protein format	Fraunhofer HDAC6